Moreover, the Company learned that some patients were previously unsuccessfully treated with other therapies, including biologics and apremilast (Otezla®).
Just incredible! I had totally forgotten about that comment. The odds of success in the Prurisol 2B trial are well above 50/50! The bar is set so much lower than the 2A trial using PASI and moderate to severe.
When is the P rally to the countdown of top line results going to begin?
News 
Market Data 
Discover 
AI
